Litovkin, Kirill <br/><br/>
Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Nov 2014 
 - 1849-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-014-1738-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Carrier Proteins--genetics<br/>Cell Cycle Proteins<br/>Cell Line, Tumor<br/>DNA Methylation<br/>Homeodomain Proteins--genetics<br/>Humans<br/>Kallikreins--blood<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--blood<br/>Promoter Regions, Genetic<br/>Proportional Hazards Models<br/>Prostate-Specific Antigen--blood<br/>Prostatic Hyperplasia--genetics<br/>Prostatic Neoplasms--blood<br/>Transcription Factors--genetics<br/>Tumor Suppressor Proteins--genetics<br/>Homeobox Protein PITX2